Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data
- PMID: 175391
- DOI: 10.1007/BF00421135
Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data
Abstract
A great number of earlier reported experimental data dealing with the role of dopamine in dopamine-loaded structures within the mammalian brain have raised questions concerning the concept of dopamine as an inhibitory agent acting on one type of receptor. A critical review of the anatomical, histochemical, electrophysiological, pharmacological and functional studies reveals that the dopamine-loaded structures are marked by an internal differentiation at various levels. It is attempted to demonstrate that this is due to a heterogeneous distribution of two distinct types of dopamine-receptors, each characterized by their own properties: DAe and DAi-receptors. Furthermore, the experimental and clinical implications are discussed in view of the hypothesis that balance between both types of receptors is essential for normal psychomotor functioning.
Similar articles
-
Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.Appl Neurophysiol. 1979;42(1-2):47-50. doi: 10.1159/000102335. Appl Neurophysiol. 1979. PMID: 222207 No abstract available.
-
Substantia nigra as a station that not only transmits, but also transforms, incoming signals for its behavioural expression: striatal dopamine and GABA-mediated responses of pars reticulata neurons.Behav Brain Res. 1983 Jan;7(1):39-49. doi: 10.1016/0166-4328(83)90003-7. Behav Brain Res. 1983. PMID: 6297521 No abstract available.
-
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.Pol J Pharmacol Pharm. 1976;28(5):469-93. Pol J Pharmacol Pharm. 1976. PMID: 796834 Review. No abstract available.
-
Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats.Brain Res. 1975 Dec 12;100(1):163-9. doi: 10.1016/0006-8993(75)90253-x. Brain Res. 1975. PMID: 1237342 No abstract available.
-
Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.Life Sci. 1980 Oct 6;27(14):1237-53. doi: 10.1016/0024-3205(80)90217-9. Life Sci. 1980. PMID: 6255271 Review. No abstract available.
Cited by
-
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.Br Med J. 1978 Apr 15;1(6118):954-6. doi: 10.1136/bmj.1.6118.954. Br Med J. 1978. PMID: 638546 Free PMC article.
-
Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling.Basic Clin Neurosci. 2019 Jan-Feb;10(1):1-12. doi: 10.32598/bcn.9.10.125. Epub 2019 Jan 1. Basic Clin Neurosci. 2019. PMID: 31031889 Free PMC article. Review.
-
Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.Psychopharmacology (Berl). 1981;74(3):271-4. doi: 10.1007/BF00427109. Psychopharmacology (Berl). 1981. PMID: 6791237
-
A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D2-Like Receptors.Int J Mol Sci. 2020 Aug 24;21(17):6103. doi: 10.3390/ijms21176103. Int J Mol Sci. 2020. PMID: 32847148 Free PMC article.
-
The biochemistry of the basal ganglia and Parkinson's disease.Postgrad Med J. 1977 Dec;53(626):719-25. doi: 10.1136/pgmj.53.626.719. Postgrad Med J. 1977. PMID: 24209 Free PMC article. Review.